Arnold/BJA Bridges Project Evaluation (009)

This supplement is to conduct an implementation process evaluation for the Bureau of Justice Assistance (BJA) and Arnold Ventures’ “Planning Initiative to Build Bridges between Jail and Community-Based Treatment for Opioid Use Disorder.” The goal of the 9-month planning initiative is to help 16 communities develop a continuum of care for providing medications for opioid use disorder (MOUDs) in jails and extending services into the community, bridging jails, community corrections, and community treatment providers.

Read More

XR:NTX vs XR:B (Brixadi) (034)

This study is conducting a comparative effectiveness trial of extended-release naltrexone (XR-NTX) versus a new extended-release formulation of buprenorphine (Brixadi, XR-B) to treat opioid use disorder (OUD) among justice-involved individuals in ten Maryland county jails.

Participants will be randomly assigned to receive either XR-NTX or XR-B prior to release from jail, followed by six monthly injections while in the community. The goal of the study is to evaluate the effectiveness of the two medications, measure medication adherence, and gather data to inform broader scale-up of medications for opioid use disorder (MOUD) in jails and in the community.

Read More